Microbiomas Foundation

microbiomas.org

Microbiomas Foundation is a basic & applied research initiative established in Colombia aiming to advance and disseminate cutting edge knowledge and innovative microbial molecular and genetic engineering applications for the greater benefit of our society and our environment, collaborating with governmental agencies and institutions and the industrial sector on microbial bioremediation, environmental biotechnology, ecogenomics and functional metagenomics by studying microbiomes composition, functions and interactions in open environments and in holobiont association.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

INVEST ONTARIO SUPPORTS NEW BIOMANUFACTURING FACILITY IN HAMILTON

Invest Ontario | April 01, 2022

news image

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson's and diabetes. OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization (CDMO), will be the anchor tenant in a new biomanufacturing campus being built in Ha...

Read More

MEDICAL

RECIPHARM AND MODERNA FINALIZE AGREEMENT TO SUPPORT FORMULATION AND FILL-FINISH A PART OF THE MODERNA COVID-19 VACCINE SUPPLY OUTSIDE OF THE U.S.

Recipharm | January 04, 2021

news image

Moderna, Inc. (NASDAQ:MRNA), biotechnology organization spearheading courier RNA (mRNA) therapeutics and vaccines, and Recipharm (STO: RECI-B), a main contract development and manufacturing organization (CDMO), today reported that they have agreed to help detailing and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the U.S. The action will be acted in Recipharm's medication item producing office located in France. Subject to regulatory approval of the imm...

Read More

MEDICAL

FAUNA BIO'S COMPARATIVE GENOMICS APPROACH FINDS NEW COMPOUNDS FOR HEART AND LUNG DISEASES

Fauna | June 15, 2022

news image

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is the first of its kind to visualize the intersection between animal gene expression data and human diseases in one comprehensive map. With Centaur, Fauna Bio is able to more rapidly identify human disease indications and targets to generate new therapeutic solutions for some of the mo...

Read More

TFF PHARMACEUTICALS AND FELIX BIOTECHNOLOGY SIGN LETTER OF INTENT FOR A COLLABORATION, DEVELOPMENT AND LICENSE AGREEMENT

Felix Biotechnology, Inc. | November 06, 2020

news image

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, and Felix Biotechnology, Inc., a clinical stage, biotherapeutic-based antibiotic development company, today jointly announce that both companies have entered into a letter of intent (LOI) which reflects the parties’ non-binding agreement in principle to negotiate and enter ...

Read More
news image

MEDICAL

INVEST ONTARIO SUPPORTS NEW BIOMANUFACTURING FACILITY IN HAMILTON

Invest Ontario | April 01, 2022

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson's and diabetes. OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization (CDMO), will be the anchor tenant in a new biomanufacturing campus being built in Ha...

Read More
news image

MEDICAL

RECIPHARM AND MODERNA FINALIZE AGREEMENT TO SUPPORT FORMULATION AND FILL-FINISH A PART OF THE MODERNA COVID-19 VACCINE SUPPLY OUTSIDE OF THE U.S.

Recipharm | January 04, 2021

Moderna, Inc. (NASDAQ:MRNA), biotechnology organization spearheading courier RNA (mRNA) therapeutics and vaccines, and Recipharm (STO: RECI-B), a main contract development and manufacturing organization (CDMO), today reported that they have agreed to help detailing and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the U.S. The action will be acted in Recipharm's medication item producing office located in France. Subject to regulatory approval of the imm...

Read More
news image

MEDICAL

FAUNA BIO'S COMPARATIVE GENOMICS APPROACH FINDS NEW COMPOUNDS FOR HEART AND LUNG DISEASES

Fauna | June 15, 2022

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is the first of its kind to visualize the intersection between animal gene expression data and human diseases in one comprehensive map. With Centaur, Fauna Bio is able to more rapidly identify human disease indications and targets to generate new therapeutic solutions for some of the mo...

Read More
news image

TFF PHARMACEUTICALS AND FELIX BIOTECHNOLOGY SIGN LETTER OF INTENT FOR A COLLABORATION, DEVELOPMENT AND LICENSE AGREEMENT

Felix Biotechnology, Inc. | November 06, 2020

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, and Felix Biotechnology, Inc., a clinical stage, biotherapeutic-based antibiotic development company, today jointly announce that both companies have entered into a letter of intent (LOI) which reflects the parties’ non-binding agreement in principle to negotiate and enter ...

Read More